Kessler, a principal at Milliman, says employers need to pay attention to their claims and pharmacy benefit contracts.

As PBMs plan for 2028 rollout of the PBM transparency provisions of the Consolidated Appropriations Act of 2026 (CAA 2026) ...

Low perceived HIV risk despite reported high-risk behaviors suggests major educational gaps in correctional settings and ...

Yes, breaking up is hard to do, acknowledged the president of Vivid Clear Rx. But employers should be "brave" about severing ...

About two-thirds of Northwell's enrollees are certified for at least one WTC-related health condition, and 30% of those have ...

A principal and product owner at Milliman, Kessler discusses some of the reasons for heightened attention and scrutiny of ...

GLP-1s account for roughly 25% of pharmacy spend and are projected to keep climbing, yet obesity did not appear among the highest-cost conditions versus cancer, MSK, and cardiovascular disease. As ...

Annual National Conference in Orlando, Florida, Amy Wadstrom, RPh, president of Vivid Clear Rx, said that a growing market ...

At the Pharmacy Benefit Management Institute's 2026 Annual National Conference in Orlando, Florida, Amy Wadstrom, RPh, ...

Federal and state laws now require PBMs to report drug pricing, rebates, and prior authorization data, creating compliance ...

FDA expands accelerated approval of oral sevabertinib for first-line HER2-mutant lung cancer, offering targeted treatment with strong response rates versus standard chemotherapy.

Kaiser Permanente’s contracting emphasizes acquisition cost and total value, enabling savings to flow to the health system ...